Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

642 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The TRAIL apoptotic pathway in cancer onset, progression and therapy.
Johnstone RW, Frew AJ, Smyth MJ. Johnstone RW, et al. Among authors: smyth mj. Nat Rev Cancer. 2008 Oct;8(10):782-98. doi: 10.1038/nrc2465. Nat Rev Cancer. 2008. PMID: 18813321 Review.
The histone deacetylase inhibitor and chemotherapeutic agent suberoylanilide hydroxamic acid (SAHA) induces a cell-death pathway characterized by cleavage of Bid and production of reactive oxygen species.
Ruefli AA, Ausserlechner MJ, Bernhard D, Sutton VR, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. Ruefli AA, et al. Among authors: smyth mj. Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10833-8. doi: 10.1073/pnas.191208598. Epub 2001 Sep 4. Proc Natl Acad Sci U S A. 2001. PMID: 11535817 Free PMC article.
Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection.
Kelly JM, Darcy PK, Markby JL, Godfrey DI, Takeda K, Yagita H, Smyth MJ. Kelly JM, et al. Among authors: smyth mj. Nat Immunol. 2002 Jan;3(1):83-90. doi: 10.1038/ni746. Epub 2001 Dec 17. Nat Immunol. 2002. PMID: 11743585
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice.
Cretney E, Takeda K, Yagita H, Glaccum M, Peschon JJ, Smyth MJ. Cretney E, et al. Among authors: smyth mj. J Immunol. 2002 Feb 1;168(3):1356-61. doi: 10.4049/jimmunol.168.3.1356. J Immunol. 2002. PMID: 11801676
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.
Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Takeda K, et al. Among authors: smyth mj. J Exp Med. 2002 Jan 21;195(2):161-9. doi: 10.1084/jem.20011171. J Exp Med. 2002. PMID: 11805143 Free PMC article.
Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide.
Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, Takeda K, Yagita H, Godfrey DI. Smyth MJ, et al. Blood. 2002 Feb 15;99(4):1259-66. doi: 10.1182/blood.v99.4.1259. Blood. 2002. PMID: 11830474
Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
Seki N, Brooks AD, Carter CR, Back TC, Parsoneault EM, Smyth MJ, Wiltrout RH, Sayers TJ. Seki N, et al. Among authors: smyth mj. J Immunol. 2002 Apr 1;168(7):3484-92. doi: 10.4049/jimmunol.168.7.3484. J Immunol. 2002. PMID: 11907109
Suberoylanilide hydroxamic acid (SAHA) overcomes multidrug resistance and induces cell death in P-glycoprotein-expressing cells.
Ruefli AA, Bernhard D, Tainton KM, Kofler R, Smyth MJ, Johnstone RW. Ruefli AA, et al. Among authors: smyth mj. Int J Cancer. 2002 May 10;99(2):292-8. doi: 10.1002/ijc.10327. Int J Cancer. 2002. PMID: 11979447
Functional significance of the perforin/granzyme cell death pathway.
Trapani JA, Smyth MJ. Trapani JA, et al. Among authors: smyth mj. Nat Rev Immunol. 2002 Oct;2(10):735-47. doi: 10.1038/nri911. Nat Rev Immunol. 2002. PMID: 12360212 Review.
P-glycoprotein inhibits caspase-8 activation but not formation of the death inducing signal complex (disc) following Fas ligation.
Ruefli AA, Tainton KM, Darcy PK, Smyth MJ, Johnstone RW. Ruefli AA, et al. Among authors: smyth mj. Cell Death Differ. 2002 Nov;9(11):1266-72. doi: 10.1038/sj.cdd.4401081. Cell Death Differ. 2002. PMID: 12404126
642 results
Jump to page
Feedback